Literature DB >> 20441547

Innate immune function of the neisserial porins and the relationship to vaccine adjuvant activity.

Lee M Wetzler1.   

Abstract

Neisseria meningitidis is a Gram-negative pathogenic bacteria responsible for bacterial meningitis and septicemia. Porins are the most represented outer membrane proteins in the pathogenic Neisseria species, functioning as pores for the exchange of ions, and are characterized by a trimeric beta-barrel structure. Neisserial porins have been shown to act as adjuvants in the immune response via activation of B cells and other antigen-presenting cells. Their effect on the immune response is mediated by upregulation of the costimulatory molecule B7-2 (CD86) on the surface of antigen-presenting cells, an effect that is dependent on Toll-like receptor (TLR)2 and MyD88, through a cascade of signal transduction events mediated by direct binding of the porin to the TLR2-TLR1 heterodimer. This article summarizes work carried out investigating the mechanisms of the immune stimulating capacity of the neisserial porins (specifically meningococcal PorB), emphasizing cellular events involved in antigen-presenting cell activation and induction of expression of cell surface molecules involved in the immune response.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20441547      PMCID: PMC2907731          DOI: 10.2217/fmb.10.41

Source DB:  PubMed          Journal:  Future Microbiol        ISSN: 1746-0913            Impact factor:   3.165


  76 in total

1.  Gonococcal porin vaccine evaluation: comparison of Por proteosomes, liposomes, and blebs isolated from rmp deletion mutants.

Authors:  L M Wetzler; M S Blake; K Barry; E C Gotschlich
Journal:  J Infect Dis       Date:  1992-09       Impact factor: 5.226

2.  Intranasal immunization with multivalent group A streptococcal vaccines protects mice against intranasal challenge infections.

Authors:  Mary A Hall; Steven D Stroop; Mary C Hu; Michael A Walls; Mark A Reddish; David S Burt; George H Lowell; James B Dale
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

3.  Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway.

Authors:  G Bjune; E A Høiby; J K Grønnesby; O Arnesen; J H Fredriksen; A Halstensen; E Holten; A K Lindbak; H Nøkleby; E Rosenqvist
Journal:  Lancet       Date:  1991-11-02       Impact factor: 79.321

4.  The bacterial porin superfamily: sequence alignment and structure prediction.

Authors:  D Jeanteur; J H Lakey; F Pattus
Journal:  Mol Microbiol       Date:  1991-09       Impact factor: 3.501

5.  Class-3 porin protein of Neisseria meningitidis: cloning and structure of the gene.

Authors:  S Butcher; M Sarvas; K Runeberg-Nyman
Journal:  Gene       Date:  1991-08-30       Impact factor: 3.688

Review 6.  Toll-Like receptors (TLRs) and their ligands.

Authors:  Satoshi Uematsu; Shizuo Akira
Journal:  Handb Exp Pharmacol       Date:  2008

7.  Immunogenicity of a Haemophilus influenzae polysaccharide-Neisseria meningitidis outer membrane protein complex conjugate vaccine.

Authors:  J J Donnelly; R R Deck; M A Liu
Journal:  J Immunol       Date:  1990-11-01       Impact factor: 5.422

8.  Haemophilus influenzae porin induces Toll-like receptor 2-mediated cytokine production in human monocytes and mouse macrophages.

Authors:  Marilena Galdiero; Massimiliano Galdiero; Emiliana Finamore; Fabio Rossano; Maria Gambuzza; Maria Rosaria Catania; Giuseppe Teti; Angelina Midiri; Giuseppe Mancuso
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

9.  The PorB porin from commensal Neisseria lactamica induces Th1 and Th2 immune responses to ovalbumin in mice and is a potential immune adjuvant.

Authors:  Xiuping Liu; Lee M Wetzler; Paola Massari
Journal:  Vaccine       Date:  2007-12-26       Impact factor: 3.641

10.  Porin of Shigella dysenteriae enhances mRNA levels for Toll-like receptor 2 and MyD88, up-regulates CD80 of murine macrophage, and induces the release of interleukin-12.

Authors:  Avijit Ray; Nabendu S Chatterjee; Sujit K Bhattacharya; Tapas Biswas
Journal:  FEMS Immunol Med Microbiol       Date:  2003-12-05
View more
  23 in total

1.  Salmonella Typhi OmpS1 and OmpS2 porins are potent protective immunogens with adjuvant properties.

Authors:  Mario A Moreno-Eutimio; Alejandra Tenorio-Calvo; Rodolfo Pastelin-Palacios; Christian Perez-Shibayama; Cristina Gil-Cruz; Rubén López-Santiago; Isabel Baeza; Marcos Fernández-Mora; Laura Bonifaz; Armando Isibasi; Edmundo Calva; Constantino López-Macías
Journal:  Immunology       Date:  2013-08       Impact factor: 7.397

2.  The FomA porin from Fusobacterium nucleatum is a Toll-like receptor 2 agonist with immune adjuvant activity.

Authors:  Deana N Toussi; Xiuping Liu; Paola Massari
Journal:  Clin Vaccine Immunol       Date:  2012-05-23

3.  Haemophilus ducreyi lipooligosaccharides induce expression of the immunosuppressive enzyme indoleamine 2,3-dioxygenase via type I interferons and tumor necrosis factor alpha in human dendritic cells.

Authors:  Wei Li; Barry P Katz; Stanley M Spinola
Journal:  Infect Immun       Date:  2011-05-16       Impact factor: 3.441

4.  Neisseriae internalization by epithelial cells is enhanced by TLR2 stimulation.

Authors:  Deana N Toussi; Lee M Wetzler; Xiuping Liu; Paola Massari
Journal:  Microbes Infect       Date:  2016-07-01       Impact factor: 2.700

Review 5.  Immune response to vaccine adjuvants during the first year of life.

Authors:  Ofer Levy; Stanislas Goriely; Tobias R Kollmann
Journal:  Vaccine       Date:  2012-10-18       Impact factor: 3.641

6.  Meningococcal PorB induces a robust and diverse antigen specific T cell response as a vaccine adjuvant.

Authors:  Munir Mosaheb; Lee M Wetzler
Journal:  Vaccine       Date:  2018-10-28       Impact factor: 3.641

7.  Saturating mutagenesis of an essential gene: a majority of the Neisseria gonorrhoeae major outer membrane porin (PorB) is mutable.

Authors:  Adrienne Chen; H Steven Seifert
Journal:  J Bacteriol       Date:  2013-11-15       Impact factor: 3.490

8.  Mutant Native Outer Membrane Vesicles Combined with a Serogroup A Polysaccharide Conjugate Vaccine for Prevention of Meningococcal Epidemics in Africa.

Authors:  Rolando Pajon; Andrew M Fergus; Dan M Granoff
Journal:  PLoS One       Date:  2013-06-21       Impact factor: 3.240

9.  Vaccines for gonorrhea: can we rise to the challenge?

Authors:  Weiyan Zhu; Ching-Ju Chen; Christopher E Thomas; James E Anderson; Ann E Jerse; P Frederick Sparling
Journal:  Front Microbiol       Date:  2011-06-03       Impact factor: 5.640

10.  The Role of TLR2 in Infection and Immunity.

Authors:  Laura Oliveira-Nascimento; Paola Massari; Lee M Wetzler
Journal:  Front Immunol       Date:  2012-04-18       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.